We are live on ! Find out more
ISPC icon

iSpecimen

10 hedge funds and large institutions have $443K invested in iSpecimen in 2025 Q3 according to their latest regulatory filings, with 6 funds opening new positions, 1 increasing their positions, 1 reducing their positions, and 3 closing their positions.

New
Increased
Maintained
Reduced
Closed

570% more capital invested

Capital invested by funds: $66.1K → $443K (+$377K)

100% more first-time investments, than exits

New positions opened: 6 | Existing positions closed: 3

43% more funds holding

Funds holding: 710 (+3)

0% more repeat investments, than reductions

Existing positions increased: 1 | Existing positions reduced: 1

3.51% less ownership

Funds ownership: 7.02%3.51% (-3.5%)

Holders
10
Holders Change
+3
Holders Change %
+42.86%
% of All Funds
0.13%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
6
Increased
1
Reduced
1
Closed
3
Calls
Puts
Net Calls
Net Calls Change

ISPC Hedge Fund Activity: Q3 2025 in Review

10 of the 7,641 institutional investors tracked by Wall St. Rank reported a position in iSpecimen (ISPC) for Q3 2025, worth a combined $443K — up 570% from $66.1K a quarter earlier.

Buyers outnumbered sellers: 6 funds opened new ISPC positions and 3 closed out — a net gain of 3 holders — while 1 added to existing stakes and 1 trimmed.

The largest buyer was Renaissance Technologies, opening a new position worth an estimated $180K. The largest seller was Citadel Advisors, exiting entirely with an estimated $19.1K sold.

  • 10 institutional investors held iSpecimen (ISPC) as of Q3 2025, up from 7 in Q2 2025.
  • Funds reported $443K of iSpecimen stock for Q3 2025, up 570% quarter-over-quarter.
  • 6 funds opened new iSpecimen positions in Q3 2025 and 3 closed out, a net change of +3 holders.
  • The largest iSpecimen buyer in Q3 2025 was Renaissance Technologies, an estimated $180K added.
  • The largest iSpecimen seller in Q3 2025 was Citadel Advisors, an estimated $19.1K sold.

Based on aggregated 13F filings for Q3 2025.